These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 28732148)
21. Nationwide Trends in Hospitalizations and In-Hospital Mortality in Granulomatosis With Polyangiitis (Wegener's). Wallace ZS; Lu N; Miloslavsky E; Unizony S; Stone JH; Choi HK Arthritis Care Res (Hoboken); 2017 Jun; 69(6):915-921. PubMed ID: 27389595 [TBL] [Abstract][Full Text] [Related]
22. Hospitalized Infections in People With Osteoarthritis: A National US Study. Singh JA; Cleveland JD J Rheumatol; 2021 Jun; 48(6):933-939. PubMed ID: 32739891 [TBL] [Abstract][Full Text] [Related]
23. Comparative Risk of Hospitalized Infection Associated With Biologic Agents in Rheumatoid Arthritis Patients Enrolled in Medicare. Yun H; Xie F; Delzell E; Levitan EB; Chen L; Lewis JD; Saag KG; Beukelman T; Winthrop KL; Baddley JW; Curtis JR Arthritis Rheumatol; 2016 Jan; 68(1):56-66. PubMed ID: 26315675 [TBL] [Abstract][Full Text] [Related]
24. A multicenter report of biologic agents for the treatment of secondary amyloidosis in Turkish rheumatoid arthritis and ankylosing spondylitis patients. Pamuk ÖN; Kalyoncu U; Aksu K; Omma A; Pehlivan Y; Çağatay Y; Küçükşahin O; Dönmez S; Çetin GY; Mercan R; Bayındır Ö; Çefle A; Yıldız F; Balkarlı A; Kılıç L; Çakır N; Kısacık B; Öksüz MF; Çobankara V; Onat AM; Sayarlıoğlu M; Öztürk MA; Pamuk GE; Akkoç N Rheumatol Int; 2016 Jul; 36(7):945-53. PubMed ID: 27221456 [TBL] [Abstract][Full Text] [Related]
25. Asymptomatic carriage of Pneumocystis jiroveci in elderly patients with rheumatoid arthritis in Japan: a possible association between colonization and development of Pneumocystis jiroveci pneumonia during low-dose MTX therapy. Mori S; Cho I; Ichiyasu H; Sugimoto M Mod Rheumatol; 2008; 18(3):240-6. PubMed ID: 18306977 [TBL] [Abstract][Full Text] [Related]
27. Severe adverse drug reactions to biological disease-modifying anti-rheumatic drugs in elderly patients with rheumatoid arthritis in clinical practice. Leon L; Gomez A; Vadillo C; Pato E; Rodriguez-Rodriguez L; Jover JA; Abasolo L Clin Exp Rheumatol; 2018; 36(1):29-35. PubMed ID: 28598787 [TBL] [Abstract][Full Text] [Related]
28. Hospitalizations of patients treated with anti-tumor necrosis factor-α agents -- a retrospective cohort analysis. Zisman D; Haddad A; Hashoul S; Laor A; Bitterman H; Rosner I; Eder L; Balbir-Gurman A; Mader R; Milman U J Rheumatol; 2013 Jan; 40(1):16-22. PubMed ID: 23070992 [TBL] [Abstract][Full Text] [Related]
29. Atherosclerotic cardiovascular disease in hospitalized patients with systemic sclerosis: higher mortality than patients with lupus and rheumatoid arthritis. Dave AJ; Fiorentino D; Lingala B; Krishnan E; Chung L Arthritis Care Res (Hoboken); 2014 Feb; 66(2):323-7. PubMed ID: 24022876 [TBL] [Abstract][Full Text] [Related]
30. Coxiella burnetii infection (Q fever) in rheumatoid arthritis patients with and without anti-TNFα therapy. Schoffelen T; Kampschreur LM; van Roeden SE; Wever PC; den Broeder AA; Nabuurs-Franssen MH; Sprong T; Joosten LA; van Riel PL; Oosterheert JJ; van Deuren M; Creemers MC Ann Rheum Dis; 2014 Jul; 73(7):1436-8. PubMed ID: 24794150 [No Abstract] [Full Text] [Related]
31. Comparison of the risk of infections in different anti-TNF agents: a meta-analysis. Liao H; Zhong Z; Liu Z; Zou X Int J Rheum Dis; 2017 Feb; 20(2):161-168. PubMed ID: 28160418 [TBL] [Abstract][Full Text] [Related]
32. Serious infections in a population-based cohort of 86,039 seniors with rheumatoid arthritis. Widdifield J; Bernatsky S; Paterson JM; Gunraj N; Thorne JC; Pope J; Cividino A; Bombardier C Arthritis Care Res (Hoboken); 2013 Mar; 65(3):353-61. PubMed ID: 22833532 [TBL] [Abstract][Full Text] [Related]
33. Incidence, mortality, and national costs of hospital admissions for potentially preventable infections in patients with rheumatoid arthritis. Potera J; Kambhatla S; Gauto-Mariotti E; Manadan A Clin Rheumatol; 2021 Dec; 40(12):4845-4851. PubMed ID: 34254210 [TBL] [Abstract][Full Text] [Related]
35. Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis. Lacaille D; Guh DP; Abrahamowicz M; Anis AH; Esdaile JM Arthritis Rheum; 2008 Aug; 59(8):1074-81. PubMed ID: 18668604 [TBL] [Abstract][Full Text] [Related]
36. Serious infections in people with systemic sclerosis: a national US study. Singh JA; Cleveland JD Arthritis Res Ther; 2020 Jun; 22(1):163. PubMed ID: 32600412 [TBL] [Abstract][Full Text] [Related]
37. Incidence of opportunistic infections in patients with rheumatoid arthritis treated with different molecular-targeted drugs: A population-based retrospective cohort study. Takabayashi K; Ando F; Ikeda K; Nakajima H; Hanaoka H; Suzuki T Mod Rheumatol; 2023 Nov; 33(6):1078-1086. PubMed ID: 36308397 [TBL] [Abstract][Full Text] [Related]
38. Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy. Wolfe F; Caplan L; Michaud K Arthritis Rheum; 2006 Feb; 54(2):628-34. PubMed ID: 16447241 [TBL] [Abstract][Full Text] [Related]
39. Incidence, Risk Factors and Outcomes of Delayed-onset Cytomegalovirus Disease in a Large Retrospective Cohort of Lung Transplant Recipients. Santos CA; Brennan DC; Yusen RD; Olsen MA Transplantation; 2015 Aug; 99(8):1658-66. PubMed ID: 25675196 [TBL] [Abstract][Full Text] [Related]
40. Infectious disease hospitalizations among older adults in the United States from 1990 through 2002. Curns AT; Holman RC; Sejvar JJ; Owings MF; Schonberger LB Arch Intern Med; 2005 Nov; 165(21):2514-20. PubMed ID: 16314549 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]